|
000
| 01627nam 2200397zi 4500 |
|---|
| 001 | 9.941542 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240823104401 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn |||||||| |
|---|
| 008 | 240807e202408 onc o f000 0 eng d |
|---|
| 020 | |a9780660730448 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-305/2024E-PDF |
|---|
| 245 | 00|aGuidance document : |bcertificates of supplementary protection. |
|---|
| 246 | 30|aCertificates of supplementary protection |
|---|
| 246 | 37|aCSP guidance document |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cAugust 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (28 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : certificats de protection supplémentaire. |
|---|
| 500 | |a"Effective date: 2024/08/19." |
|---|
| 500 | |a"Pub.: 240421." |
|---|
| 650 | 0|aPatent medicines|zCanada. |
|---|
| 650 | 0|aPatent extensions|zCanada. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.941541 |
|---|
| 795 | |tGuidance document : |w9.931029 |
|---|
| 856 | 40|qPDF|s518 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-305-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/register-certificates/certificate-supplementary-protection-regulations.html |
|---|